486 related articles for article (PubMed ID: 33777674)
1.
Luo P; Zheng M; Zhang R; Zhang H; Liu Y; Li W; Sun X; Yu Q; Tipoe GL; Xiao J
Acta Pharm Sin B; 2021 Mar; 11(3):668-679. PubMed ID: 33777674
[TBL] [Abstract][Full Text] [Related]
2. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
3. Garlic-derived compound
Xiao J; Xing F; Liu Y; Lv Y; Wang X; Ling MT; Gao H; Ouyang S; Yang M; Zhu J; Xia Y; So KF; Tipoe GL
Acta Pharm Sin B; 2018 Jul; 8(4):575-586. PubMed ID: 30109182
[TBL] [Abstract][Full Text] [Related]
4. Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model.
Xiao J; Ching YP; Liong EC; Nanji AA; Fung ML; Tipoe GL
Eur J Nutr; 2013 Feb; 52(1):179-91. PubMed ID: 22278044
[TBL] [Abstract][Full Text] [Related]
5. Effect of Korean Red Ginseng on metabolic syndrome.
Yoon SJ; Kim SK; Lee NY; Choi YR; Kim HS; Gupta H; Youn GS; Sung H; Shin MJ; Suk KT
J Ginseng Res; 2021 May; 45(3):380-389. PubMed ID: 34025131
[TBL] [Abstract][Full Text] [Related]
6. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
7. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
8. Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats.
Shen L; Liu Z; Gong J; Zhang L; Wang L; Magdalou J; Chen L; Wang H
Toxicol Appl Pharmacol; 2014 Jan; 274(2):263-73. PubMed ID: 24275070
[TBL] [Abstract][Full Text] [Related]
9. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
10. Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice.
Inamdar S; Joshi A; Malik S; Boppana R; Ghaskadbi S
Biochem Biophys Res Commun; 2019 Oct; 519(1):106-112. PubMed ID: 31472955
[TBL] [Abstract][Full Text] [Related]
11. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.
Ziamajidi N; Khaghani S; Hassanzadeh G; Vardasbi S; Ahmadian S; Nowrouzi A; Ghaffari SM; Abdirad A
Food Chem Toxicol; 2013 Aug; 58():198-209. PubMed ID: 23603006
[TBL] [Abstract][Full Text] [Related]
12. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway.
Liu Y; Xu W; Zhai T; You J; Chen Y
Acta Pharm Sin B; 2019 Jul; 9(4):745-757. PubMed ID: 31384535
[TBL] [Abstract][Full Text] [Related]
13. S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways.
Mo M; Li S; Dong Z; Li C; Sun Y; Li A; Zhao Z
Int Immunopharmacol; 2020 Apr; 81():106273. PubMed ID: 32070920
[TBL] [Abstract][Full Text] [Related]
14. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
[TBL] [Abstract][Full Text] [Related]
15. Hydroxytyrosol attenuates ethanol-induced liver injury by ameliorating steatosis, oxidative stress and hepatic inflammation by interfering STAT3/iNOS pathway.
Fang X; Cao J; Tao Z; Yang Z; Dai Y; Zhao L
Redox Rep; 2023 Dec; 28(1):2187564. PubMed ID: 36932927
[No Abstract] [Full Text] [Related]
16. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice.
Choi S; Choi Y; Choi Y; Kim S; Jang J; Park T
Food Chem; 2013 Dec; 141(4):3627-35. PubMed ID: 23993530
[TBL] [Abstract][Full Text] [Related]
17. Aqueous Extract of Pepino (
Hsu JY; Lin HH; Hsu CC; Chen BC; Chen JH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037014
[TBL] [Abstract][Full Text] [Related]
18. S-allylmercaptocysteine improves nonalcoholic steatohepatitis by enhancing AHR/NRF2-mediated drug metabolising enzymes and reducing NF-κB/IκBα and NLRP3/6-mediated inflammation.
Yu Q; Lee YY; Xia ZY; Liong EC; Xiao J; Tipoe GL
Eur J Nutr; 2021 Mar; 60(2):961-973. PubMed ID: 32556446
[TBL] [Abstract][Full Text] [Related]
19. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
20. Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice.
Chen WY; Zhang J; Ghare S; Barve S; McClain C; Joshi-Barve S
Cell Mol Gastroenterol Hepatol; 2016 Sep; 2(5):685-700. PubMed ID: 28119953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
